| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.23 | 4e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.24 | 4e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |